FDA includes stent grafts in tracking list

08/27/2008 | FDAnews

The FDA has included thoracic aortic aneurysm stent grafts in a list of medical devices that require monitoring, according to a final guidance issued last week. Class II or III devices may be subjected to the FDA's tracking requirements because of various factors, including risk of adverse health effects.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC